PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 31 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $347,531 | +2.7% | 68,818 | +2.3% | 0.00% | – |
Q2 2023 | $338,373 | -47.0% | 67,271 | -35.2% | 0.00% | – |
Q1 2023 | $638,738 | -78.4% | 103,860 | -53.6% | 0.00% | – |
Q4 2022 | $2,953,303 | +6320.2% | 223,735 | +1350.9% | 0.00% | – |
Q3 2022 | $46,000 | -11.5% | 15,420 | +7.3% | 0.00% | – |
Q2 2022 | $52,000 | -49.5% | 14,371 | -13.6% | 0.00% | – |
Q1 2022 | $103,000 | -38.0% | 16,625 | -18.7% | 0.00% | – |
Q4 2021 | $166,000 | +95.3% | 20,450 | +257.1% | 0.00% | – |
Q3 2021 | $85,000 | -89.7% | 5,726 | -91.3% | 0.00% | – |
Q2 2021 | $825,000 | +6246.2% | 65,703 | +2254.9% | 0.00% | – |
Q1 2021 | $13,000 | +225.0% | 2,790 | +64.1% | 0.00% | – |
Q4 2020 | $4,000 | -71.4% | 1,700 | -72.1% | 0.00% | – |
Q3 2020 | $14,000 | – | 6,100 | +22492.6% | 0.00% | – |
Q4 2019 | $0 | – | 27 | -48.1% | 0.00% | – |
Q3 2019 | $0 | – | 52 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 52 | -5.5% | 0.00% | – |
Q1 2019 | $0 | – | 55 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
tru Independence LLC | 500 | $0 | 0.00% |
Renaissance Technologies | 120,269 | $319,000 | 0.00% |
D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |